Literature DB >> 8648125

The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice.

R W Burlingame1, M A Volzer, J Harris, T W Du Clos.   

Abstract

The clearance of nucleosome core particles and H1-stripped chromatin from the circulation of mice was examined. Radiolabeled chromatin preparations were injected into mice, and blood samples were obtained over 60 min. The animals were then killed, and the selected organs were collected and radioactivity was measured. The acute phase response (APR) was induced by i.p. injections of casein before some clearance studies. Serum amyloid P component, the major acute phase protein in mice, increased from 27 microg/ml to 339 microg/ml during the acute phase. The rate of chromatin clearance decreased during the acute phase in C57BL/10J mice. At 5 min, 18% +/- 3% of the originally measured radioactivity remained in control animals compared with 49% +/- 2% in acute phase animals (p < 0.001). Co-injection of either serum amyloid P component or C-reactive protein, the major acute phase protein in humans, caused a decrease in the rate of chromatin clearance similar to that observed following the induction of the APR. APR induction also caused a higher percentage of the chromatin to localize in the liver compared with the spleen, with the ratio changing from 10.2 +/- 0.7 to 16.1 +/- 1.9 (p < 0.004). In addition, the APR caused a decrease in the percentage of chromatin localized in the kidney. The lack of radioactivity associated with cells in the circulation indicates that complement is not a major factor in the clearance mechanism of chromatin. These findings suggest that the APR produces major changes in the rate and path of chromatin clearance. These changes may protect against deposition of chromatin in target organs of systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648125

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Varied biologic functions of C-reactive protein: lessons learned from transgenic mice.

Authors:  Alexander J Szalai; Mark A McCrory
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Complexes of serum amyloid P component and DNA in serum from healthy individuals and systemic lupus erythematosus patients.

Authors:  I J Sørensen; E Holm Nielsen; L Schrøder; A Voss; L Horváth; S E Svehag
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

3.  Chromatin clearance in C57Bl/10 mice: interaction with heparan sulphate proteoglycans and receptors on Kupffer cells.

Authors:  T W Du Clos; M A Volzer; F F Hahn; R Xiao; C Mold; R P Searles
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 4.  The interaction of C-reactive protein and serum amyloid P component with nuclear antigens.

Authors:  T W Du Clos
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

5.  Plasma C-reactive protein in early pregnancy and preterm delivery.

Authors:  Waranuch Pitiphat; Matthew W Gillman; Kaumudi J Joshipura; Paige L Williams; Chester W Douglass; Janet W Rich-Edwards
Journal:  Am J Epidemiol       Date:  2005-10-19       Impact factor: 4.897

6.  A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.

Authors:  Juulia Jylhävä; Leo-Pekka Lyytikäinen; Mika Kähönen; Nina Hutri-Kähönen; Johannes Kettunen; Jorma Viikari; Olli T Raitakari; Terho Lehtimäki; Mikko Hurme
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

7.  Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance.

Authors:  Catalina Trejo-Becerril; Luis F Oñate-Ocaña; Lucía Taja-Chayeb; América Vanoye-Carlo; Lucely Cetina; Alfonso Duenas-Gonzalez
Journal:  BMC Cancer       Date:  2005-06-27       Impact factor: 4.430

8.  Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity.

Authors:  Xiaoyan Shi; Chun Xie; Desi Kreska; James A Richardson; Chandra Mohan
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.